ConductScience.org, home

Paper8551246

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.

Young JW and 1 other. J Exp Med, 1996. Cited by 272 papers, by iCite.

Cite this record

ConductScience Library. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. Papers, record 8551246. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8551246

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.
PubMed
Journal
J Exp Med
PubMed
Year
1996
PubMed
Publication types
Comment, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
272
iCite
Relative citation ratio, by iCite
5.54
iCite
Revised in PubMed
2019-05-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Young JWJ W
2Inaba KK

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Antigens, NeoplasmMajor topic
Dendritic CellsMajor topic
Histocompatibility Antigens Class IMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Immunotherapy
Mice

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-26875NIAID NIH HHSUnited StatesR01AI026875PubMed and NIHNIH RePORTER
CA-23766NCI NIH HHSUnited StatesP01CA023766PubMed and NIHNIH RePORTER
R29AI026875NIHNIH RePORTER

Download CSV of grants

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment on8551233Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.https://conductscience.org/library/papers/8551233PubMed
Comment on8551239Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.https://conductscience.org/library/papers/8551239PubMed
Comment on8551248Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.https://conductscience.org/library/papers/8551248PubMed

Download CSV of comments and corrections

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12965021Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.Eur J Immunol1988https://conductscience.org/library/papers/2965021PubMed
28145033
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
J Exp Med1994https://conductscience.org/library/papers/8145033PubMed
32179270Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.J Clin Invest1990https://conductscience.org/library/papers/2179270PubMed
42139102Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.J Exp Med1990https://conductscience.org/library/papers/2139102PubMed
52373994Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.J Exp Med1990https://conductscience.org/library/papers/2373994PubMed
62212951Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.J Exp Med1990https://conductscience.org/library/papers/2212951PubMed
72026885Tumor antigen presentation by murine epidermal cells.J Immunol1991https://conductscience.org/library/papers/2026885PubMed
81910679The dendritic cell system and its role in immunogenicity.Annu Rev Immunol1991https://conductscience.org/library/papers/1910679PubMed
91730522Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells.Int J Cancer1992https://conductscience.org/library/papers/1730522PubMed
101546558Toward a genetic analysis of tumor rejection antigens.Adv Cancer Res1992https://conductscience.org/library/papers/1546558PubMed
111569392Identification of proliferating dendritic cell precursors in mouse blood.J Exp Med1992https://conductscience.org/library/papers/1569392PubMed
121378854The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.J Clin Invest1992https://conductscience.org/library/papers/1378854PubMed
131387891TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages.J Leukoc Biol1992https://conductscience.org/library/papers/1387891PubMed
141383322
Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
J Immunol1992https://conductscience.org/library/papers/1383322PubMed
151279441GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.Nature1992https://conductscience.org/library/papers/1279441PubMed
161460426Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.J Exp Med1992https://conductscience.org/library/papers/1460426PubMed
171335364Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.Cell1992https://conductscience.org/library/papers/1335364PubMed
187678351Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.Science1993https://conductscience.org/library/papers/7678351PubMed
197679425Expression and function of B7 on human epidermal Langerhans cells.J Immunol1993https://conductscience.org/library/papers/7679425PubMed
208478609Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo.J Exp Med1993https://conductscience.org/library/papers/8478609PubMed

See all 48 referencesDownload CSV of references

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 272 citations.

PMIDTitleJournalYearIn PapersSource
24434331Novel adjuvants & delivery vehicles for vaccines development: a road ahead.Indian J Med Res2013https://conductscience.org/library/papers/24434331PubMed
24273000Inflammation and TCR signal strength determine the breadth of the T cell response in a bim-dependent manner.J Immunol2014https://conductscience.org/library/papers/24273000PubMed
23039887Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.Clin Exp Immunol2012https://conductscience.org/library/papers/23039887PubMed
22475929From genes to drugs: targeted strategies for melanoma.Nat Rev Cancer2012https://conductscience.org/library/papers/22475929PubMed
21541197Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.J Biomed Biotechnol2011https://conductscience.org/library/papers/21541197PubMed
21048993Regulation of tumor immunity by tumor/dendritic cell fusions.Clin Dev Immunol2010https://conductscience.org/library/papers/21048993PubMed
20618329
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.
Br J Haematol2010https://conductscience.org/library/papers/20618329PubMed
20091029Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function.Cancer Immunol Immunother2010https://conductscience.org/library/papers/20091029PubMed
19221746Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses.Cancer Immunol Immunother2009https://conductscience.org/library/papers/19221746PubMed
18834548Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells.J Transl Med2008https://conductscience.org/library/papers/18834548PubMed
16713981Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.Immunity2006https://conductscience.org/library/papers/16713981PubMed
16133115Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model.Cancer Immunol Immunother2006https://conductscience.org/library/papers/16133115PubMed
15925989Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.J Neurooncol2005https://conductscience.org/library/papers/15925989PubMed
15819706Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.Immunology2005https://conductscience.org/library/papers/15819706PubMed
15565181Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells.Cancer Gene Ther2005https://conductscience.org/library/papers/15565181PubMed
15163415Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus.J Clin Virol2004https://conductscience.org/library/papers/15163415PubMed
15147037Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.Hum Cell2003https://conductscience.org/library/papers/15147037PubMed
15124022Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine.J Clin Invest2004https://conductscience.org/library/papers/15124022PubMed
12847287CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12847287PubMed
12789295GM-CSF-secreting melanoma vaccines.Oncogene2003https://conductscience.org/library/papers/12789295PubMed

See all 59 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8551246

GET https://conductscience.org/api/papers/v1/8551246/references?page=2